NCT01361620View on ClinicalTrials.gov

Genotypic and Phenotypic Correlates of Resistance to Aspirin

NACompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Platelet Dysfunction Due to Aspirin
Interventions
DRUG

aspirin

aspirin 81mg, 7-10 days

Trial Locations (1)

20037

GWU Medical Faculty Associates, Washington D.C.

All Listed Sponsors
lead

George Washington University

OTHER

NCT01361620 - Genotypic and Phenotypic Correlates of Resistance to Aspirin | Biotech Hunter | Biotech Hunter